These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2115633)

  • 1. Subclavian vein thrombosis treated with recombinant tissue plasminogen activator.
    Diskin CJ; Thomas CE; Lock S; Campagna KD
    Nephrol Dial Transplant; 1990; 5(5):400. PubMed ID: 2115633
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid resolution of subclavian vein thrombosis by tissue plasminogen activator.
    Stewart A; Mayne EE
    Lancet; 1988 Apr; 1(8590):890. PubMed ID: 2895402
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombolysis with recombinant tissue plasminogen activator in late saphenous vein graft thrombosis.
    Blanck Z; Cheirif J; Blick DR; Harris SL; Heibig J
    Am Heart J; 1990 Apr; 119(4):952-3. PubMed ID: 2138846
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of retavase and urokinase for management of spontaneous subclavian vein thrombosis.
    Gelabert HA; Jimenez JC; Rigberg DA
    Ann Vasc Surg; 2007 Mar; 21(2):149-54. PubMed ID: 17349354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal vein thrombosis repermeabilization with rt-PA.
    Mies S; Alfieri Júnior F; Chamone DF; Raia S
    Thromb Haemost; 1991 Jan; 65(1):108. PubMed ID: 1902594
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombolytic properties in a rabbit jugular vein thrombosis model of a tissue-type plasminogen activator mutant lacking the growth factor- and kringle 1-domains.
    Emeis JJ; Verheijen JH
    Ann N Y Acad Sci; 1992 Dec; 667():421-3. PubMed ID: 1309064
    [No Abstract]   [Full Text] [Related]  

  • 7. Locoregional fibrinolysis using tissue plasminogen activator in 2 cases of acute thrombosis of the renal artery.
    Giorgetti PL; Lovaria A; Saccheri S; Arpesani A; Rignano A; Bortolani EM; Galimberti M
    Panminerva Med; 1991; 33(4):180-4. PubMed ID: 1806875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis with recombinant tissue-type plasminogen activator in renal venous thrombosis in infancy.
    Nowak-Göttl U; Schwabe D; Schneider W; Schlösser R; Kreuz W
    Lancet; 1992 Oct; 340(8827):1105. PubMed ID: 1357502
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of pulse-sprayed recombinant tissue plasminogen activator for deep venous thrombosis.
    Horne MK; Chang R
    Thromb Res; 2003; 111(1-2):111-4. PubMed ID: 14644088
    [No Abstract]   [Full Text] [Related]  

  • 10. Effort thrombosis in a young wrestler. A case report.
    Medler RG; McQueen DA
    J Bone Joint Surg Am; 1993 Jul; 75(7):1071-3. PubMed ID: 8335667
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant tissue plasminogen activator.
    Bell SG
    Neonatal Netw; 1996 Sep; 15(6):13-8. PubMed ID: 8932068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful lysis of a septic thrombosis of the superior vena cava using recombinant tissue-plasminogen activator].
    Schranz D; Haugwitz D; Zimmer B; Schumacher R
    Klin Padiatr; 1991; 203(5):363-5. PubMed ID: 1942943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute deep vein thrombosis of lower limbs treated by thrombolytic therapy with recombinant tissue-type plasminogen activator].
    Wu JD; Guan H; Wang SH; Liu CW; Jin YF; Liu B; Ye W; Zeng R
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):491-2. PubMed ID: 15854559
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination thrombolytic and anticoagulant therapy for bilateral renal vein thrombosis in a premature infant.
    Weinschenk N; Pelidis M; Fiascone J
    Am J Perinatol; 2001 Aug; 18(5):293-7. PubMed ID: 11552182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine upper extremity thrombosis successfully treated with recombinant tissue plasminogen activator, enoxaparin and collagenase.
    Yurttutan S; Ozdemir R; Erdeve O; Calisici E; Oncel MY; Oguz SS; Dilmen U
    Acta Haematol; 2012; 127(3):189-92. PubMed ID: 22398687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reteplase thrombolysis for treatment of mechanical valve thrombosis.
    Schultz SC; D Ambra P
    J Invasive Cardiol; 2003 Mar; 15(3):156. PubMed ID: 12612392
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombolytic therapy in children--clinical experiences with recombinant tissue-plasminogen activator.
    Knöfler R; Dinger J; Kabus M; Müller D; Lauterbach I; Rupprecht E; Taut-Sack H; Weissbach G
    Semin Thromb Hemost; 2001; 27(2):169-74. PubMed ID: 11372772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children.
    Jacobs BR; Haygood M; Hingl J
    J Pediatr; 2001 Oct; 139(4):593-6. PubMed ID: 11598611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
    Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK
    Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant tissue-type plasminogen activator in the treatment of acute renal artery thrombosis after kidney transplantation.
    Garcia A; Vedula G; Nowygrod R; Ratner LE; Goldstein MJ
    Am J Transplant; 2010 Aug; 10(8):1931-3. PubMed ID: 20636457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.